HRCI-HRB Joint Funding Scheme 2024- Translational Biomedical Research – Areas of Unmet Need in Cancer
Introduction
We are pleased to announce that the Irish Cancer Society is accepting applications as part of the HRCI-HRB Joint Funding Scheme 2024.
The Irish Cancer Society is a member of Health Research Charities Ireland (HRCI- formerly Medical Research Charities Group), which was founded in 1998 with the aim of supporting charities in Ireland to increase both the quality and quantity of healthcare research being done in Ireland. The HRCI represents the joint interests of charities specialising in restoring health through medical research, diagnosis and treatment and, where possible, the prevention of disease.
The HRCI-HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each charity.
The Irish Cancer Society will run our own call based on our strategic priorities, but will be using the standard application guidance and forms provided by the HRB.
The theme for the Irish Cancer Society call as part of the HRCI-HRB Joint Funding Scheme is Translational Biomedical Research – Areas of Unmet Need in Cancer.
Applications must focus on cancers with significant challenges and unmet needs, addressing one (or more) of our four strategic aims for this call:
1) cancers in which there are significant challenges in terms of outcome (i.e. metastatic cancers, rare cancers, poor response or poor outcome cancers)
2) cancers affecting children, adolescents and young adults
3) novel approaches for improving early detection, diagnosis or treatment
4) research which seeks to improve outcomes amongst traditionally underserved communities.
Please see the Guidelines for Applicants for more information
Funding
HRCI-HRB awards are up to a maximum total award value of €300,000 for projects from 12 - 36 months in duration.
How to apply
Applicants must email grants@irishcancer.ie with a complete ‘intention to submit’ form, by Thursday 21st September 2023. The template for the intention to submit form can be found below. The intention to submit form must provide an outline of the application, including:
- Proposed Project Title
- 5 Keywords
- Which strategic area(s) is the proposed project addressing
- Lead Applicant
*Please note, the purpose of the intention to submit form is to allow us to anticipate the number of full applications that we will receive, and to aid the Society in selecting the most appropriate peer reviewers for the full applications. This form will not be peer reviewed or used in the decision-making process for this award. Everyone who submits an intention to submit form is entitled to also submit a full application.
Full applications must then be submitted by email to grants@irishcancer.ie by the deadline of 3.00pm, Thursday, 19th October 2023.
For a full list of eligibility criteria please refer to our guidance document, and the HRB Guidance document for applicants, below.
Key dates*
Thursday 21st September 2023 | Intention to Submit deadline |
3pm Thursday, 19th October 2023 | Deadline for full applications |
November 2023-January 2024 | Irish Cancer Society external peer review |
January 2024 | Applicant Response |
February 2024 | Charity Selection Committee |
Late March 2024 | HRB Application Deadline |
July 2024 | Applicant Notification |
From October 2024 | Research Project Start Date |
For any queries relating to this call, please contact grants@irishcancer.ie
For further information on the HRCI-HRB Joint Funding Scheme, please go to: